Most Recent M&A and Finance Deals

Among the mergers, acquisitions and finance deals our attorneys have worked on, we represented:

Condeco Software

A U.K.-based leading global provider of office utilization and workspace scheduling solutions, in the acquisition of myVRM, a New York-based software company with workflow automation experience in video collaboration, content sharing, unified communications, virtual meetings and analytics.

The acquisition, which was announced on June 15, 2016, will allow Condeco to offer a combined platform that simplifies video collaboration.

Deal Team:

Ted D. Rosen
Tel: 212.878.7931

NeuWave Medical, Inc.

A privately held medical device company that manufactures and markets minimally invasive soft-tissue microwave ablation systems, through a major acquisition by Ethicon Endo-Surgery, Inc., a medical device company, which is part of the Johnson & Johnson family of companies. Financial terms of the transaction, which closed on April 13, 2016, have not been disclosed.

Deal Team:

Bill Kaufman
Tel: 612.607.7485
Cynthia S. Topel
Tel: 612.607.7342
Gina DeConcini
Tel: 612.607.7377
Phillip B. Martin
Tel: 612.607.7352
Pamela A. Thein
Tel: 612.607.7408
Sandi De Boom
Tel: 612.607.7262

PuraCap Pharmaceutical LLC

A New Jersey-based fully integrated pharmaceutical company, and its parent company Humanwell Healthcare Group Co., Ltd. (SHA: 600079), a China-based life sciences company, in their $550 million acquisition of Epic Pharma, LLC. The acquisition will further establish Humanwell and PuraCap in the U.S. generics market and expand their existing commercial and manufacturing capabilities. The deal was announced on March 31, 2016. Under the terms of the agreement, the acquisition is subject to certain conditions, and the transaction is expected to close in the second quarter of 2016.

Deal Team:

Jianming Jimmy Hao, Ph.D.
Tel: 609.895.7065
Matthew R. Kittay
Tel: 212.878.7978
Loren David Danzis
Tel: 215.918.3561
Ted D. Rosen
Tel: 612.607.7502
Alexander S. Radus
Tel: 215.918.3566
Andrew M. Halbert
Tel: 312.517.9204
Jean W. Frydman
Tel: 609.895.6630
Michael S. Bookbinder
Tel: 215.299.2818
Jeffrey H. Nicholas
Tel: 215.918.3639

Paddy Power

As New Jersey regulatory counsel in the Ireland-based online company’s recent multibillion-dollar merger with UK-based Betfair to create Paddy Power Betfair PLC, the world’s largest public online betting and gaming company. The combined companies have a gross revenue of $1.65 billion and profit before tax of $327.8 million. The deal closed on February 1, 2016.

Deal Team:

Nicholas Casiello, Jr.
Tel: 609.572.2234
Patrick Madamba, Jr.
Tel: 609.572.2286

MGM Resorts International (NYSE: MGM)

As Maryland regulatory counsel for the financing of MGM National Harbor, LLC, a new casino destination in Prince George's County, Maryland. The new $1.3 billion project will create thousands of local jobs and bolster the regional economy. The deal was announced on February 1, 2016 and is expected to be completed by the end of 2016.

Deal Team:

Nicholas Casiello, Jr.
Tel: 609.572.2234
Patrick Madamba, Jr.
Tel: 609.572.2286

RestorGenex Corporation (OTCQX:RESX)

An Illinois-based public specialty biopharmaceutical company, in its merger with Virginia-based Diffusion Pharmaceuticals, a privately held clinical stage biotechnology company. The all-stock transaction closed on January 8, 2016.

Deal Team:

Amy Culbert
Tel: 612.607.7287
Brett Hanson
Tel: 612.607.7330

Healthcare Providers Insurance Exchange (HPIX)

A top 10 insurer of physician commercial medical professional liability in the Mid-Atlantic, in an acquisition in which HPIX’s rights, title, interests and policies were acquired by Medical Mutual Insurance Company of North Carolina, a leading provider of medical professional liability for physicians in the Southeast. The acquisition closed on January 1, 2016.

Deal Team:

Peter Buckley
Tel: 215.299.2854
Carl Maio
Tel: 215.918.3616
Alison Newman
Tel: 215.918.3543

Aqua America, Inc. (NYSE: WTR)

One of the largest U.S.-based, publicly traded water utilities, in its Pennsylvania subsidiary’s acquisition of Superior Water Company, Inc. The deal closed on January 1, 2016.

Deal Team:

Peter J. Tucci
Tel: 215.918.3562
Alison Newman
Tel: 215.918.3543

M&Q Plastic Products

A family-owned company, in the sale of its operating affiliate, M&Q Packaging Corp., a manufacturer of innovative, proprietary high-temperature resistant thermoplastic nylon and polyester films, to an affiliate of Capital Partners, a private investment firm. The sale closed on December 31, 2015.

Deal Team:

William R. Wanger
Tel: 610.397.6503
Andrew D. Santana
Tel: 610.397.7965


Ellen M. Enters
Tel: 610.397.6505
Eric N. Spangler
Tel: 610.397.3926

Bix Produce Company, LLC

A leader in specialty produce distribution throughout the Twin Cities metro area, greater Minnesota, Western Wisconsin, and Fargo, ND, in the sale of 100 percent of its membership interest to a private equity firm. The deal closed on December 21, 2015.

Deal Team:

Michael D. Zalk
612.607.7517
Brett Hanson
Tel: 612.607.7330
Andrea L. Ravich
Tel: 612.607.7270

Automotive Service, Inc. (ASI)

A family-owned-and-operated fuels and lubricants distributor, in its acquisition by RelaDyne, one of the nation’s leading providers of lubricants, fuel, diesel exhaust fluid and industrial reliability services. ASI will strategically expand RelaDyne’s geographic footprint further into Eastern Pennsylvania and upstate New York, providing additional avenues for lubricant and fuel sales as well as expansion of industrial reliability solutions. The deal closed on December 17, 2015.

Deal Team:

Terrence kerwin
Tel: 610.458.6186
Michael J. Meehan
Tel: 610.458.2991

Naturi, Inc

A premium organic food company, in its sale of Series A Preferred Stock. The financing closed on December 17, 2015.

Deal Team:

Terrence kerwin
Tel: 610.458.6186
James Singer
Tel: 412.391.2486

ReliefBand Technologies LLC

A digital neurotechnology company that provides leading edge personalized medical treatment, in a $5 million Series A funding. The round was led by PathoCapital, a Chicago-based specialty health care fund. The investment will fuel the consumer market introduction of the Company’s digital, FDA-cleared, wearable device for the drug-free treatment of nausea. The financing closed on December 15, 2015. The Company’s technology was originally developed by Abbott Laboratories as part of its suite of oncology products.

Deal Team:

Jeffrey H. Nicholas
Tel: 215.918.3639
Alexander Radus
Tel: 215.918.3566

The Chemistry Research Solution LLC (TCRS)

A chemistry and bioconjugation company based near Philadelphia, in its acquisition by Abzena plc (AIM:ABZA), a British life sciences technology and services company, for $15 million. Under the terms of the deal, Abzena acquired TCRS for $8.8 million in cash, $1.5 million in assumed debt and the remainder in stock. The transaction closed on December 11, 2015.

Deal Team:

Michael harrington
Tel: 610.458.4957
Terrence kerwin
Tel: 610.458.6186
Michael J. Meehan
Tel: 610.458.2991